Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer

IMPORTANCE: Randomized clinical trials have defined the survival benefit provided by the addition of biologic drugs to chemotherapy in patients with metastatic colorectal cancer (mCRC). However, Black patients may be underrepresented in trial populations, and outcomes in this group remain poorly def...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Sanjay, Negassa, Abdissa, Acuna-Villaorduna, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674750/
https://www.ncbi.nlm.nih.gov/pubmed/34910154
http://dx.doi.org/10.1001/jamanetworkopen.2021.36378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674750/
https://www.ncbi.nlm.nih.gov/pubmed/34910154
http://dx.doi.org/10.1001/jamanetworkopen.2021.36378

Ejemplares similares